ROCKET PHARMACEUTICALS, INC. 8-K
Research Summary
AI-generated summary
Rocket Pharmaceuticals Reports Q1 2026 Financial Results
What Happened
Rocket Pharmaceuticals, Inc. (RCKT) announced certain financial information for the quarter ended March 31, 2026. The company furnished a press release dated May 7, 2026, as Exhibit 99.1 to its Form 8-K (Item 2.02), reporting quarterly results and financial condition information.
Key Details
- Announcement date: May 7, 2026.
- Reporting period: Quarter ended March 31, 2026 (Q1 2026).
- Filing: Form 8-K (Item 2.02) furnished a press release as Exhibit 99.1.
- Ticker: RCKT (Rocket Pharmaceuticals, Inc.).
Why It Matters
This 8-K alerts investors that Rocket has released its latest quarterly financial information; investors should read the furnished press release (Exhibit 99.1) for revenue, expenses, cash position, and any commentary on operations or guidance. The Form 8-K itself does not add analysis beyond the press release, so follow-up with the full press release and subsequent filings (10-Q or other disclosures) for complete financial details and context.